太原同济医院中医肿瘤科
太原同济医院中医肿瘤科
当前位置:主页 > 淋巴癌 > 淋巴癌的早期症状 >

    【2020EHA抢先看】时隔一年,中国之声再度唱响!

    发布时间:2020-05-16  来源:未知  作者:木木

    整理:肿瘤资讯
    来源:肿瘤资讯

    2020年新型冠状病毒肺炎的疫情全球肆虐,但疫情并未阻挡学术的进步与分享。第25届欧洲血液学协会(EHA)年会在众多期待中如约而来。与今年的ASCO一样,今年的EHA同样采取了线上虚拟网络会的模式。当地时间5月14日15:00,大会摘要公布。小编第一时间检索出12篇中国专家在本届EHA的口头发言,并简要整理,以供大家参考。

    (按摘要号排列先后)

    欧洲血液不协会年会kv.jpg

    河北燕达陆道培医院团队:多色流式细胞术联合CCD79A设门检测B淋巴细胞白血病/淋巴瘤患者CD19 CAR-T治疗后的微小残留病变

    标题:MULTICOLOR FLOW CYTOMETRY PANEL WITH CCD79A GATING TO DETECT MINIMAL RESIDUAL DISEASE IN PATIENTS WITH B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA POST ANTI-CD19 CAR-T THERAPY BRIDGING TO ALLO-HSCT

    作者:Man Chen Hui Wang Minjing Fu , Aixian Wang, Meiwei GONG Junyi Zhen Xueying Wu

    摘要号:S113

    陆军军医大学第二附属医院(重庆新桥医院)张曦教授团队:首个人类通用CD7 CAR-T治疗复发难治性T细胞急性淋巴细胞白血病(R/R T-ALL)的研究

    标题:FIRST-IN-HUMAN, UNIVERSAL ANTI-CD7 CAR-T THERAPY FOR RELAPSED AND REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R T-ALL)

    作者:Xinxin Wang, Shiqi Li, Lei Gao, Zhongtao Yuan, Kun Wu, Lin Liu, Le Luo, Yao Liu, Cheng Zhang, Jia Liu, Chunhui Yang, Yu Li, Jiaping He, Xun Ye, Zhimin Li, Duanpeng Wang, Jianning Ge, Xu Tan, Ruihao Huang, Cong Han, Yu Han, Martina Sersch, Dingsong Zhang, Youcheng Wang, Lihua Fang, Yingnian Chen, Wei Cao, Sanbin Wang, Xi Zhang

    摘要号:S115

    成都军区总医院刘芳教授团队:首次人类CLL1-CD33复合CAR(CCAR)T细胞治疗复发难治性急性髓系白血病的研究

    标题:FIRST-IN-HUMAN CLL1-CD33 COMPOUND CAR (CCAR) T CELL THERAPY IN RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA

    作者:Fang Liu , Hongyu Zhang , Lihua Sun , Yecheng Li , Shan Zhang , Guangcui He , Hai Yi , Masayuki Wada , Kevin G Pinz , Kevin H Chen , Yu Ma , Yisong Xiong , Yi Su , Yupo Ma

    摘要号:S149 

    高博医疗团队童春容、张永红教授团队:以不同B细胞抗原为靶点的CAR-T细胞序贯治疗难治/复发性Burkitt淋巴瘤的疗效与安全性

    标题:EFFICACY AND SAFETY OF SEQUENTIAL ADMINISTRATION OF CAR T CELLS TARGETING DIFFERENT B CELL ANTIGEN IN CHILDREN WITH REFRACTORY/RELAPSED BURKITT LYMPHOMA

    作者:Ying Liu, Biping Deng, Bo Hu, Wenqun Zhang, Qing Zhu, Alex H Chang, Yang Liu, Shan Wang, Ying Yang, Chunrong Tong, Yonghong Zhang

    摘要号:S242

    北京大学人民医院黄晓军教授团队:

    --三氧化二砷通过调节巨噬细胞极化减轻急性移植物抗宿主病

    --Basiliximab治疗类固醇难治性急性移植物抗宿主病的预后因素和长期随访:一项大规模研究的经验更新

    --单倍体造血干细胞移植后不同巨细胞病毒终末器官疾病危险因素及病死率比较

    标题:ARSENIC TRIOXIDE ALLEVIATES ACUTE GRAFT-VERSUS-HOST DISEASE BY MODULATING MACROPHAGE POLARIZATION

    作者:Xiao Liu, Yan Su, Xiao-jun Huang, Xiao-hui Zhang

    摘要号:S254 

    标题:PROGNOSTIC FACTORS AND LONG-TERM FOLLOW-UP OF BASILIXIMAB FOR STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE: UPDATED EXPERIENCES FROM A LARGE-SCALE STUDY

    作者:Si-Ning Liu, Lan-Ping Xu, Xiao-Hui Zhang, Yu Wang, Chen-Hua Yan, Yu-Hong Chen, Huan Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Fei-Fei Tang, Yi-Fei Cheng, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Dong Mo

    摘要号:S257

    标题:COMPARISON OF RISK FACTORS AND MORTALITY OF DIFFERENT CYTOMEGALOVIRUS END-ORGAN DISEASES FOLLOWING HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

    作者:xing-ye meng, hai-xia fu, xiao liu, jing-zhi wang, feng-rong wang, chen-hua yan, yuan-yuan zhang, xiao-dong mo, yu wang, wei han, yu-hong chen, ding-bao chen, ying-jun chang, lan-ping xu, kai-yan liu, xiao-jun huang, xiao-hui zhang

    摘要号:S263

    苏州大学附属第一医院吴德沛教授团队:低剂量地西他滨改善造血干细胞移植后难治性血小板减少症的随机、多中心临床试验

    标题:LOW-DOSE DECITABINE IMPROVES REFRACTORY PROLONGED ISOLATED THROMBOCYTOPENIA AFTER HEMATOPOIETIC CELL TRANSPLANTATION: A RANDOMIZED MULTICENTER CLINICAL TRIAL

    作者:Yaqiong Tang, Jia Chen, Tiantian Chu, Qifa Liu, Jianying Liang, Xuefeng He, Feng Chen, Weiyang Li, Ting Yang, Xiao Ma, Xiaojin Wu, Shaoyan Hu, Xingyu Cao, Xiaohui Hu, Jiong Hu, Yi Fan, Yuejun Liu, Chengsen Cai, Meng Zhou, Changgeng Ruan, Yue Han, Depei Wu

    摘要号:S260 

    广州南方春富(儿童)血液病研究院李春富教授团队:重型地中海贫血患者的双“保险”双次HSCT:移植后环磷酰胺HAPLO-HSCT联合非亲缘脐血移植

    标题:A DOUBLE-INSURANCE DUAL HSCT IN PATIENT WITH THALASSEMIA MAJOR: POST-TRANSPLANT CYCLOPHOSPHAMIDE HAPLO-HSCT FOLLOWED BY UNRELATED CORD BLOOD TRANSPLANTATION

    作者:Chunfu Li, Sixi Liu, Yuelin He, Xiaodong Wang, Jianyun Liao, Shan Li, Xiaolin Zhang, Xuedong Wu, Changgang Li, Xiaoqin Feng, Feiqiu Wen, Huaying Liu, Xiaohui Zhou, Zhiyong Peng, Lan He, Chaoke Pu, Wing Leung

    摘要号:S266 

    苏州大学唐仲英医学研究院血液学研究中心杨林教授团队:纳米抗体源性抗CD7嵌合抗原受体T细胞(CAR-T)对CD7阳性肿瘤有抗肿瘤活性

    标题:CD7 NANOBODY-DERIVED ANTI-CD7 CHIMERIC ANTIGEN RECEPTOR T-CELLS EXHIBITED POTENT ANTI-TUMOR ACTIVITIES TO CD7 POSITIVE MALIGNANCIES

    作者:Dan Chen , Fengtao You , Yinyan Wang , Yu-Sheng Chen , Mingzhi Zhang , Lei Zhang , Shufen Xiang , Min Wang , Yu Wang , Guifang Pan , Hanying Xu , Dandan Liu , Xiangxiang Liang , Huimin Meng , Yanmei Zhao , Bozhen Zhang , Lin Yang

    摘要号:S279 

    郑州大学第一附属医院张明智教授团队:自体CD7 CAR-T细胞治疗复发难治性急性淋巴细胞白血病/淋巴瘤的首次临床试验

    标题:FIRST-IN-HUMAN CLINICAL TRIAL OF THE AUTOLOGOUS CD7-CART CELLS FOR PATIENTS WITH RELAPSED AND REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

    作者:Mingzhi Zhang, Xiaorui Fu, Lei Zhang, Huimin Meng, Ling Li, Xin Li, Xinhua Wang, Zhenchang Sun, Hui Yu, Zhaoming Li, Feifei Nan, Yu Chang, Zhiyuan Zhou, Jiaqin Yan, Jiwei Li, Min Wang, Fengtao You, Dan Chen, Yu-Sheng Chen, Guifang Pan, Hanying Xu, Bozhen Zhang, Lin Yang

    摘要号:S289

    山东齐鲁医院彭军教授团队:糖皮质激素受体通过线粒体代谢调控髓源性抑制细胞参与治疗免疫性血小板减少症

    标题:GLUCOCORTICOID RECEPTOR MODULATES MYELOID-DERIVED SUPPRESSOR CELLS FUNCTION VIA MITOCHONDRIAL METOBOLISM IN IMMUNE THROMBOCYTOPENIA

    作者:Shaoqiu Leng,Jun Peng

    摘要号:S317

    责任编辑:Amiee
    排版编辑:Amiee




    上一篇:【2020ASCO抢先看】白血病治疗领域,入选口头发言
    下一篇:没有了

友情链接

一级A做爰片高清片 2018午夜福利 操死你 东京热图 日本一级理论日本电影HD 欧美三级在线现看中文 AV免费国岛大片18禁 成 人影片 免费观看中文字幕 黃色带三级 免费 一级A看片在线观看 亚洲欧美AV中文日韩二区 欧美日韩AV无码在线 男女做爰视频 免费 国产精品亚洲在钱视频 欧美色在线 四虎影库在线永久影院免费观看 插插网 男人将机机桶女人30分钟 亚洲、欧美图区偷拍 美女被插 日韩三级 男人插曲女人网站 交换的一天 电影 在线成本人视频动漫 国产成 人 综合 亚洲 2019精品国产品在线18年 色快播 日本WWW.在线中文字幕